Elsevier

Behaviour Research and Therapy

Volume 61, October 2014, Pages 12-22
Behaviour Research and Therapy

Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care

https://doi.org/10.1016/j.brat.2014.07.004Get rights and content

Highlights

  • DBT treatment was delivered in routine outpatient care.

  • Direct and indirect costs were assessed from a societal perspective.

  • Compared to pre-treatment, substantial savings in societal costs were found during DBT.

  • Cost savings were mainly due to reduced hospitalization.

  • During follow-up year, savings in societal costs were further extended.

Abstract

Societal cost-of-illness in a German sample of patients with borderline personality disorder (BPD) was calculated for 12 months prior to an outpatient Dialectical Behavior Therapy (DBT) program, during a year of DBT in routine outpatient care and during a follow-up year. We retrospectively assessed resource consumption and productivity loss by means of a structured interview. Direct costs were calculated as opportunity costs and indirect costs were calculated according to the Human Capital Approach. All costs were expressed in Euros for the year 2010. Total mean annual BPD-related societal cost-of-illness was €28026 (SD = €33081) during pre-treatment, €18758 (SD = €19450) during the DBT treatment year for the 47 DBT treatment completers, and €14750 (SD = €18592) during the follow-up year for the 33 patients who participated in the final assessment. Cost savings were mainly due to marked reductions in inpatient treatment costs, while indirect costs barely decreased. In conclusion, our findings provide evidence that the treatment of BPD patients with an outpatient DBT program is associated with substantial overall cost savings. Already during the DBT treatment year, these savings clearly exceed the additional treatment costs of DBT and are further extended during the follow-up year. Correspondingly, outpatient DBT has the potential to be a cost-effective treatment for BPD patients. Efforts promoting its implementation in routine care should be undertaken.

Introduction

Borderline personality disorder (BPD) is a severe mental disorder that is characterized by high instability in affect regulation, impulse control, interpersonal relationships and self-image (Lieb, Zanarini, Schmahl, Linehan, & Bohus, 2004) and occurs in up to 2.7% of the general adult population (Trull, Jahng, Tomko, Wood, & Sher, 2010). There are many indications that BPD is associated with high cost-of-illness. From a societal perspective, cost-of-illness include all costs regardless of the payer and consist of direct costs related to medical and non-medical resource consumption and indirect costs due to loss of productivity. BPD patients use mental health services to a greater extent than patients with major depression (Bender et al., 2001, Bender et al., 2006) and patients with other personality disorders (Bender et al., 2001, Hörz et al., 2010). Thereby, on average, BPD patients are first hospitalized for psychiatric reasons at the age of 21 and first seek many other psychiatric and psychotherapeutic treatments between the age of 18 and 25 (Zanarini, Frankenburg, Khera, & Bleichmar, 2001), a critical period for professional development. Accordingly, there seems to be a strong relationship between BPD and poor occupational functioning. Skodol et al. (2002) found that in comparison to patients with major depression, a significantly higher proportion of BPD patients were disabled and significantly fewer were employed. Jackson and Burgess (2004) showed that among all personality disorders, BPD had the strongest association with lost days of role functioning. Furthermore, compared to remitted BPD patients, non-remitted BPD patients were more likely to have quitted or lost their jobs due to their impaired state of health (Frankenburg & Zanarini, 2004).

Despite these indications, BPD-related costs have rarely been investigated comprehensively. According to the only state-of-the-art cost-of-illness study assessing direct and indirect costs including 88 BPD patients seeking an outpatient psychotherapeutic treatment, BPD-related societal cost-of-illness in the Netherlands were substantial, amounting to €21120 (€16852)1 per BPD patient per year (Van Asselt, Dirksen, Arntz, & Severens, 2007). It is important to note that slightly more than 50% of total costs were indirect costs, mostly due to work disability, underlining the importance of completing comprehensive cost investigations. Additionally, several studies investigated BPD-related direct costs during the year preceding inpatient or outpatient psychotherapy. On average, these were €15088 in Germany (DM 24000; Jerschke, Meixner, Richter, & Bohus, 1998), €38771 (treatment group: US $44487, treatment-as-usual (TAU) group: US $52562; Bateman & Fonagy, 2003) and €16779 in Great Britain (treatment group: £7860, TAU group: £5240, each reported for a six-month period; Palmer et al., 2006) and €19978 in Australia (AUS $25526; Hall, Caleo, Stevenson, & Meares, 2001). A direct comparison between these results is impeded by a wide range of cost components included in the cost calculations in these investigations.

At the same time that BPD is associated with high costs and BPD patients are heavy users of mental health treatments that are seldom specifically designed for their disorder (Jobst, Hörz, Birkhofer, Martius, & Rentrop, 2010), there are several disorder-specific and clinically effective psychological treatments for BPD patients. Of these, Dialectical Behavior Therapy (DBT; Linehan, 1993a, Linehan, 1993b) has been studied most intensely in numerous randomized controlled trials (RCTs) and has the greatest empirical evidence concerning clinical efficacy (Stoffers et al., 2012). In particular, DBT was observed to be effective in reducing self-injurious and suicidal behavior, as well as in reducing psychiatric hospital days and emergency room visits (e.g. Koons et al., 2001, Linehan et al., 1991, McMain et al., 2009). Moreover, evidence indicates that these improvements can be maintained over a two-year follow-up period (McMain, Guimond, Streiner, Cardish, & Links, 2012).

Based on these results related to the clinical efficacy of DBT, one can reasonably assume that DBT also has great economic potential. Accordingly, Heard (2000) found that the total mean annual direct costs of BPD patients were €9210 (US $9889) lower when patients participated in outpatient DBT (€9178 respectively US $9856) compared to TAU (€18388 respectively US $19745) in the US. While treatment costs for outpatient psychotherapy were higher in the DBT group, these were offset by lower psychiatric inpatient and emergency room costs. Similarly, in an Australian trial by Pasieczny and Connor (2011), total direct costs per patient during a six month time interval were €8301 (AUS $12196) in the DBT group and €12335 (AUS $18123) in the TAU condition, resulting in cost savings of €4034 (AUS $ 5927) that again were primarily due to significantly lower inpatient costs. In contrast to these findings, in a sample of self-harming patients with any personality disorder diagnosis, total mean annual direct costs in the DBT group (€6310 respectively £5685) exceeded those in the TAU group (€4167 respectively £3754) by €2143 (£1931; Priebe, Bhatti, & Barn, 2012). Further, Brazier et al. (2006) undertook economic evaluations of four RCTs that had investigated the efficacy of DBT. Total direct costs from the governmental perspective were estimated on the basis of data from the RCTs and a cost regression model. Whereas the estimated total mean annual direct costs of patients treated with DBT and TAU were on a comparable scale in two studies (DBT: €19941 respectively £15691, TAU: €21475 respectively £16898, Linehan et al., 1991; DBT: €22151 respectively £17430, TAU: €21231 respectively £16706, Van den Bosch, Verheul, Schippers, & Van den Brink, 2002), the direct costs in the DBT group were considerably higher than in the TAU group in one study (DBT: €29787 respectively £23439, TAU: €18828 respectively £14815, Koons et al., 2001) and lower in another study (DBT: €20007 respectively £15743, TAU: €24026 respectively £20985, Turner, 2000).

In the present study, we assessed from the societal perspective the BPD-related cost-of-illness in a German sample of BPD patients in the 12 months prior to inclusion in a one-year outpatient DBT program. We further investigated BPD-related societal cost-of-illness during that specific year of outpatient DBT administered in the regular health-care system in the city of Berlin and during the following year. Following the results of Heard (2000) and Pasieczny and Connor (2011), we hypothesized that mostly due to the reduction of BPD-related inpatient treatment, the overall societal cost-of-illness during the DBT treatment year are lower than those in the year preceding DBT treatment. Also, in accordance with the findings of McMain et al. (2012), we expected that the presumed cost reduction is maintained during the follow-up year.

Section snippets

Materials and methods

The present investigation was conducted as part of a Berlin-wide treatment study (“Berliner Borderline Versorgungsstudie”; abbr.: BBV) evaluating the effectiveness of DBT in a naturalistic setting on the basis of a pre-post design with follow-up assessments. BBV was conducted at Charité-Universitätsmedizin Berlin and approved by the Charité's ethics committee. The methodology of this trial has been described in detail elsewhere (Stiglmayr et al., in revision).

Study participants

Socio-demographic and clinical characteristics at the time of study inclusion for the 47 patients who completed DBT treatment are shown in Table 2. Additionally, THI-data (average amount of BPD-related hospital and outpatient psychotherapeutic treatment utilization in the ten years prior to study inclusion) are presented (in Table 2).

Resource consumption and productivity loss

In Table 3, the mean annual amount of BPD-related resource consumption and mean annual amount of productivity loss during the three assessment periods is reported.

Main findings

In the present study, we assessed societal cost-of-illness in a German sample of BPD patients during three one-year periods: the year preceding outpatient DBT, the year of outpatient DBT in routine care and the follow-up year. Four major findings emerge from our study.

First, BPD poses a high economic burden that exceeds that of many other mental disorders. In the present study, BPD-related total societal cost-of-illness amounted to €28026 per patient during the year preceding DBT treatment,

Acknowledgments

We are grateful to all patients, therapists and research assistants (Friederike Horstmann, Lars Jensen, Sara Matthies, Suzan Monz, Heidi Päpke and Anke Rauch) who took part in this trial. We thank our colleagues on the Berliner Borderline Versorgungsstudie Jeanette Meißner, Doreen Spretz, Julia Stecher-Mohr, Christiane Steffens for assistance in conducting the study. We thank Claudia Dambacher, Dieter Gieb and Sara Matthies for their assistance in calculating (unit) costs. We thank Christian

References (66)

  • P. Andlin-Sobocki et al.

    Cost of anxiety disorders in Europe

    European Journal of Neurology

    (2005)
  • A. Bateman et al.

    Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care

    American Journal of Psychiatry

    (2003)
  • D.S. Bender et al.

    Treatment utilization by patients with personality disorders

    American Journal of Psychiatry

    (2001)
  • D.S. Bender et al.

    Prospective assessment of treatment use by patients with personality disorders

    Psychiatric Services

    (2006)
  • M. Bohus et al.

    Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomized controlled trial

    Psychotherapy and Psychosomatics

    (2013)
  • J. Brazier et al.

    Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation

    Health Technology Assessment

    (2006)
  • Bundesarbeitsgemeinschaft der Träger PsychiatrischerKrankenhäuser

    Psychiatrie im Bundesvergleich. Auswertung der Budgetvereinbarungen 2009 sowie weiterer Kennziffern der psychiatrischen Krankenhäuser aus dem Bundesland als interner Krankenhausvergleich gem. § 5 BPflV

    (2009)
  • W. Chung

    Psychiatric inpatient expenditures and public health insurance programs: analysis of a national database covering the entire South Korean population

    BMC Health Services Research

    (2010)
  • J. Coid et al.

    Borderline personality disorder: health service use and social functioning among a national household population

    Psychological Medicine

    (2009)
  • K.A. Comtois et al.

    Recovery from disability for individuals with borderline personality disorder: a feasibility trial of DBT-Aces

    Psychiatric Services

    (2010)
  • A. Dams et al.

    Das Skillstraining und die poststationäre Effektivität der stationären Dialektisch-Behavioralen Therapie (DBT) nach sechs Monaten

    Psychotherapie Psychosomatik·Medizinische Psychologie

    (2007)
  • Eikelmann et al.

    A second labour market? Vocational rehabilitation and work integration of chronically mentally ill people in Germany

    Acta Psychiatrica Scandinavica

    (1993)
  • Eurostat

    HICP-inflation rate. Annual average rate of change (%)

    (2013)
  • M.B. First et al.

    Structured clinical interview for DSM-IV Axis II personality disorders (SCID-II)

    (1997)
  • M.B. First et al.

    Structured clinical interview for DSM-IV-TR Axis I disorders, research Version, Patient Edition (SCID-I/P)

    (2002)
  • F.R. Frankenburg et al.

    The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization

    Journal of Clinical Psychiatry

    (2004)
  • J.G. Gunderson et al.

    Ten-year course of borderline personality disorder. Psychopathology and function from the collaborative longitudinal personality disorder study

    Archives of General Psychiatry

    (2011)
  • J. Hall et al.

    An economic analysis of psychotherapy for borderline personality disorder patients

    The Journal of Mental Health Policy Economics

    (2001)
  • H.L. Heard

    Cost-effectiveness of dialectical behavior therapy for borderline personality disorder

    Dissertation Abstracts International Section B: Sciences and Engineering

    (2000)
  • M.L.M. Hermens et al.

    Barriers to implementing the clinical guideline on borderline personality disorder in the Netherlands

    Psychiatric Services

    (2011)
  • S. Hollis et al.

    What is meant by intention to treat analysis? Survey of published randomized controlled trials

    British Medical Journey

    (1999)
  • S. Hörz et al.

    Ten-year use of mental health services by patients with borderline personality disorder and with other axis II disorders

    Psychiatric Services

    (2010)
  • H.J. Jackson et al.

    Personality disorders in the community: results from the Australian national survey of mental health and well-being part III. Relationships between specific type of personality disorder, axis 1 mental disorder and physical conditions with disability and health consultations

    Social Psychiatry and Psychiatric Epidemiology

    (2004)
  • Cited by (64)

    • Emergency psychiatric management of borderline personality disorder: Towards an articulation of modalities for personalised integrative care

      2020, Encephale
      Citation Excerpt :

      These differences should be considered in relation to the GDP per capita and the cost of the hospital day per country. Among these studies, some have also taken into account indirect costs (loss of productivity, job loss, suicide, etc.) to establish the total annual cost per person to society: 11,300 € in Spain [58], 21,100 € in the Netherlands [59], 28,000 € in Germany [60]. These figures show that health costs account for 23% to 54% of the total cost to society.

    View all citing articles on Scopus
    View full text